Abstract
Catatonia is a syndrome, comprised of symptoms such as motor immobility, excessive motor activity, extreme negativism, and stereotyped movements. Neuroleptic is able to induce catatonia like symptoms, that is, the neuroleptic malignant syndrome (NMS). In NMS, patients typically show symptoms such as an altered mental state, muscle rigidity, tremor, tachycardia, hyperpyrexia, leukocytosis, and elevated serum creatine phosphorous kinase. Several researchers have reported studies on catatonia and the association between catatonia and NMS, but none were from this part of the eastern India. In our case, we observed overlapping symptoms of catatonia and NMS; we wish to present a case of this diagnostic dilemma in a patient with catatonia, where a detailed history, investigation, and symptom management added as a great contribution to the patient's rapid improvement.
References
Nov 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·M M Woodbury, M A Woodbury
Dec 1, 1991·The Australian and New Zealand Journal of Psychiatry·J J ReillyJ H Lloyd
Aug 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·E M Jones, A Dawson
May 1, 1993·Psychological Medicine·A M O'Dwyer, N P Sheppard
Jan 1, 1996·Biological Psychiatry·M Fink
Apr 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·G NorthoffJ Fritze
Aug 12, 1998·The American Journal of Psychiatry·S Hasan, P Buckley
Mar 24, 2000·Revista de neurologia·M de EntrambasaguasW Schonewille
Feb 24, 2001·Journal of Clinical Psychopharmacology·M Fink
Apr 3, 2001·The International Journal of Neuropsychopharmacology·Thomas Mathews, Yekeen A. Aderibigbe
Oct 7, 2005·Pharmacotherapy·Jui-Hsiu TsaiMing-Jen Yang
May 16, 2006·International Review of Neurobiology·Dirk Marcel DhosscheTressa D Carroll
Apr 2, 2013·Indian Journal of Pharmacology·Bichitra Nanda PatraMamta Sood